| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.007 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |